Citation:
Date Published:
SEPAbstract:
We present a new approach for the covalent inhibition of HIV-1 integrase (IN) by an LEDGF/p75-derived peptide modified with an N-terminal succinimide group. The covalent inhibition is mediated by direct binding of the succinimide to the amine group of a lysine residue in IN. The peptide serves as a specific recognition sequence for the target protein, while the succinimide serves as the binding moiety. The combination of a readily synthesizable peptide precursor with easy and efficient binding to the target protein makes this approach a promising new strategy for designing lead compounds.
Notes:
![cmd](https://mattanhurevich.huji.ac.il/sites/default/files/styles/os_files_xxlarge/public/mattan_hurevich/files/cmdc201600190-toc-0001-m.jpg?m=1665039091&itok=hEdHxeso)